Briana J. Jegier

Briana J. Jegier

Auto-generated profile, based on publicly available information

Briana J. Jegier

College of Nursing, Rush University Medical Center, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2016 in Maternal & Child Nutrition
Verified
Journal Article
Closed access
PDF file
MBMelissa C. Bartick
Melissa C. Bartick
ESEleanor Bimla Schwarz
Eleanor Bimla Schwarz
BGBrittany D. Green
Brittany D. Green
BJBriana J. Jegier
Briana J. Jegier
ARArnold G. Reinhold
Arnold G. Reinhold
ASAlison M. Stuebe
Alison M. Stuebe

31 January 2013 in Journal of Perinatology
Verified
Journal Article
Open access
PDF file
APAloka L. Patel
Aloka L. Patel
TJT J Johnson
T J Johnson
JEJ L Engstrom
J L Engstrom
LFL F Fogg
L F Fogg
BJB J Jegier
B J Jegier
PMP P Meier
P P Meier
Objective: To study the incidence of sepsis and neonatal intensive care unit (NICU) costs as a function of the human milk (HM) dose received during the first 28 days post birth for very low birth weight (VLBW) infants. Study design: Prospective cohort study of 175 VLBW infants. The average daily dose of HM (ADDHM) was calculated from daily nutritional data for the first 28 days post birth (ADDHM-Days 1–28). Other covariates associated with sepsis were used to create a propensity score, combining multiple risk factors into a single metric. Result: The mean gestational age and birth weight were 28.1±2.4 weeks and 1087±252 g, respectively. The mean ADDHM-Days 1–28 was 54±39 ml kg−1 day−1 (range 0–135). Binary logistic regression analysis controlling for propensity score revealed that increasing ADDHM-Days 1–28 was associated with lower odds of sepsis (odds ratio 0.981, 95% confidence interval 0.967–0.995, P=0.008). Increasing ADDHM-Days 1–28 was associated with significantly lower NICU costs. Conclusion: A dose–response relationship was demonstrated between ADDHM-Days 1–28 and a reduction in the odds of sepsis and associated NICU costs after controlling for propensity score. For every HM dose increase of 10 ml kg−1 day−1, the odds of sepsis decreased by 19%. NICU costs were lowest in the VLBW infants who received the highest ADDHM-Days 1–28.

1 February 2013 in The Journal of Pediatrics
Verified
Journal Article
Closed access
Tricia J JohnsonTricia J Johnson
Tricia J Johnson
APAloka L. Patel
Aloka L. Patel
BJBriana J. Jegier
Briana J. Jegier
JEJanet L. Engstrom
Janet L. Engstrom
PMPaula P. Meier
Paula P. Meier

1 March 2010 in Clinics in Perinatology
Verified
Journal Article
Closed access
PMPaula Meier
Paula Meier
JEJanet L. Engstrom
Janet L. Engstrom
APAloka L. Patel
Aloka L. Patel
BJBriana J. Jegier
Briana J. Jegier
NBNicholas E. Bruns
Nicholas E. Bruns

21 May 2009 in Journal of Perinatology
Verified
Journal Article
Open access
PDF file
APAloka L. Patel
Aloka L. Patel
JEJ L Engstrom
J L Engstrom
PMP P Meier
P P Meier
BJB J Jegier
B J Jegier
RKR E Kimura
R E Kimura
Objective: Currently, there is no standardized approach to the calculation of growth velocity (GV; g kg –1 day–1) in hospitalized very low birth weight (VLBW) infants. Thus, differing methods are used to estimate GV, resulting in different medical centers and studies reporting growth results that are difficult to compare. The objective of this study was to compare actual GV calculated from infant daily weights during hospitalization in a Neonatal Intensive Care Unit (NICU) with estimated GV using two mathematical models that have been shown earlier to provide good estimated GVs in extremely low birth weight (ELBW) infants: an exponential model (EM) and a 2-Point model (2-PM). Study Design: Daily weights from 81 infants with birth weights (BWs) of 1000 to 1499 g were used to calculate actual GV in daily increments from two starting points: (1) birth and (2) day of life (DOL) of regaining BW. These daily GV values were then averaged over the NICU stay to yield overall NICU GV from the two starting points. We compared these actual GV with estimated GV calculated using the EM and 2-PM methods. Results: The mean absolute difference between actual and EM estimates of GV showed <1% error for 100% of infants from both starting points. The mean absolute difference between actual and 2-PM estimates showed <1% error for only 38 and 44% of infants from birth and regaining BW, respectively. The EM was unaffected by decreasing BW and increasing length of NICU stay, whereas the accuracy of the 2-PM was diminished significantly (P<0.001) by both factors. Conclusion: In contrast to the 2-PM, the EM provides an extremely accurate estimate of GV in larger VLBW infants, and its accuracy is unaffected by common infant factors. The EM has now been validated for use in all VLBW infants to assess growth and provides a simple-to-use and consistent approach.

1 August 2014 in The Spine Journal
Verified
Journal Article
Closed access
KSKern Singh
Kern Singh
SNSreeharsha V. Nandyala
Sreeharsha V. Nandyala
AMAlejandro Marquez-Lara
Alejandro Marquez-Lara
SFSteven J. Fineberg
Steven J. Fineberg
MOMathew Oglesby
Mathew Oglesby
FPFrank M. Phillips
Frank M. Phillips